sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 476-500 out of 1311.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>

Public Release: 23-Feb-2016
Bacteria overgrowth could be major cause of stunting in children
Excessive growth of bacteria in the small intestine could be damaging the gut of young children, leading to stunting, scientists from the US and Bangladesh have discovered.

Contact: Josh Barney
University of Virginia Health System

Public Release: 23-Feb-2016
Dietary link to stunted growth identified
A team of researchers has found that inadequate dietary intake of essential amino acids and the nutrient choline is linked to stunting, a debilitating condition that affects millions of children worldwide.
National Institutes of Health, Intramural Research Program of the National Institute on Aging, Children's Discovery Institute of Washington University and St. Louis Children's Hospital, Hickey Family Foundation

Contact: Judy Martin Finch
Washington University School of Medicine

Public Release: 23-Feb-2016
Society of Critical Care Medicine's 45th Critical Care Congress
Feinstein Institute researcher presents new definitions for sepsis and septic shock
Clifford S. Deutschman, MS, MD, vice chair of research in the Department of Pediatrics at Cohen Children's Medical Center and an investigator at The Feinstein Institute for Medical Research, presented new definitions and clinical criteria for sepsis and septic shock at the Society of Critical Care Medicine's (SCCM) 45th Critical Care Congress in Orlando, FL. He was also corresponding author for an article outlining the findings that was published February 23 in The Journal of the American Medical Association.

Contact: Emily Ng
Northwell Health

Public Release: 23-Feb-2016
2016 Conference on Retroviruses and Opportunistic Infections
Option B+ to prevent maternal transmission of HIV shows rise in women initiating therapy
The first findings from a study in the Kingdom of Swaziland on a new approach to reduce mother to child transmission of HIV were presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston. show that implementation of Option B+ greatly increased the number of women initiating ART and dramatically improved ART coverage among pregnant women.

Contact: Stephanie Berger
Columbia University's Mailman School of Public Health

Public Release: 23-Feb-2016
Food-based proteins discovered as key to child malnutrition in developing countries
Contrary to popular belief among world relief workers, children in developing countries may not be eating enough protein, which could contribute to stunted growth, a Johns Hopkins-directed study suggests.

Contact: Marin Hedin
Johns Hopkins Medicine

Public Release: 23-Feb-2016
Proceedings of the Royal Society B
Tackling Zika -- using bacteria as a Trojan horse
Bacteria in the gut of disease-bearing insects -- including the mosquito which carries the Zika virus -- can be used as a Trojan horse to help control the insects' population, new research at Swansea University has shown. The results showed declines in fertility of up to 100 percent and an increase of 60 percent in the mortality rate of larvae, among the insects studied. The findings offer the prospect of a much more targeted approach to insect control.

Contact: Kevin Sullivan
Swansea University

Public Release: 23-Feb-2016
PLOS Medicine
Health and development in infants after mefloquine antimalarial treatment during pregnancy
Early development does not appear to be affected in children born to mothers who were treated with the antimalarial mefloquine during pregnancy compared to children of mothers treated with sulfadoxine-pyrimethamine, according to research appearing this week in PLOS Medicine.

Contact: PLOS Medicine

Public Release: 22-Feb-2016
2016 Conference on Retroviruses and Opportunistic Infections
New England Journal of Medicine
Vaginal ring provides partial protection from HIV in large multinational trial
A ring that continuously releases an experimental antiretroviral drug in the vagina safely provided a modest level of protection against HIV infection in women, a large clinical trial in four sub-Saharan African countries has found. The ring reduced the risk of HIV infection by 27 percent in the study population overall and by 61 percent among women ages 25 years and older, who used the ring most consistently.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Laura S. Leifman
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 22-Feb-2016
2016 Conference on Retroviruses and Opportunistic Infections
Two large studies show IPM's monthly vaginal ring helps protect women against HIV
Two large Phase III clinical trials -- The Ring Study and ASPIRE -- have shown that a monthly vaginal ring containing the antiretroviral drug dapivirine can safely help prevent HIV-1 infection in women. Developed by the nonprofit International Partnership for Microbicides (IPM), the monthly ring is the first long-acting HIV prevention method designed for women, who bear the greatest burden of the global HIV/AIDS epidemic. IPM plans to apply for regulatory approval to license the product.
Ministry of Foreign Affairs of Denmark, Flanders Department of Foreign Affairs, Irish Aid, Ministry of Foreign Affairs of the Netherlands, Norwegian Agency for Development Cooperation, United Kingdom Department for International Development

Contact: Holly Seltzer
International Partnership for Microbicides (IPM)

Public Release: 22-Feb-2016
One drug used to prevent HIV transmission during pregnancy shows evidence of developmental effects
The antiretroviral drug atazanavir -- sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy -- may have small but significant effects on infant development, reports a study in the journal AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 22-Feb-2016
ACS Nano
A portable device for rapid and highly sensitive diagnostics
A portable and low-cost diagnostic device has been developed at EPFL. This microfluidic tool, which has been tested with Ebola, requires no bulky equipment. It is thus ideally suited for use in remote regions.

Contact: francesco.piraino@epfl.ch
Ecole Polytechnique Fédérale de Lausanne

Public Release: 19-Feb-2016
Seeking Zika: Where and when will Zika-carrying mosquitoes strike next?
Zika: the virus has emerged as a major public health threat that's rapidly spreading through South and Central America and the Caribbean.
National Science Foundation

Contact: Cheryl Dybas
National Science Foundation

Public Release: 19-Feb-2016
Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor
A research team that included scientists from The Scripps Research Institute has identified a new group of powerful antibodies to fight Ebola virus. The antibodies, isolated from the blood of a survivor of the 2014 Ebola outbreak and the largest panel reported to date, could guide the development of a vaccine or therapeutic against Ebola.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Diseases Center for Excellence in Translational Research, National Science Foundation fellowship, Defense Advanced Research Projects Agency

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 19-Feb-2016
Lancet Respiratory Medicine
Blood test could transform tuberculosis diagnosis, treatment in developing countries
A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year.

Contact: Jennie Dusheck
Stanford University Medical Center

Public Release: 18-Feb-2016
Engineering to the rescue: Fighting kidney disease in rural Sri Lanka
Backed by a grant from the US Environmental Protection Agency (EPA), an interdisciplinary, student-led team from New Jersey Institute of Technology is building a low-cost water filter for villagers in the north central farming region of Sri Lanka who are suffering from high rates of chronic kidney disease.
US Environmental Protection Agency

Contact: Tanya Klein
New Jersey Institute of Technology

Public Release: 18-Feb-2016
Proceedings of the National Academy of Sciences
Scientists discover way to potentially track and stop human and agricultural viruses
The discovery has broad ranging applications in stopping viral outbreaks such as hepatitis C in humans and a number of viruses in plants and animals because it applies to many viruses in the largest category of viral classes -- positive-strand RNA viruses.

Contact: Zeke Barlow
Virginia Tech

Public Release: 18-Feb-2016
PLOS Pathogens
Wolbachia parasite superinfection: A new tool to fight mosquito arbovirus transmission
Aedes aegypti mosquitoes transmit a number of pathogens, including the Dengue, Chikungunya, and Zika viruses. The Wolbachia bacterium can be introduced into the Aedes aegypti population and then block virus replication in the infected mosquito host. As with any antiviral strategy, the potential development of resistance by the virus is a concern. A study published on Feb. 18, 2016 in PLOS Pathogens reports on a strategy to make it harder for Dengue (and possibly other viruses) to develop Wolbachia resistance.

Contact: Cameron Simmons

Public Release: 17-Feb-2016
AIDS Research and Human Retroviruses
Progress toward an HIV cure highlighted in special issue of AIDS Research and Human Retroviruses
A cure for HIV/AIDS is the ultimate goal of rapidly advancing research involving diverse and innovative approaches. A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 17-Feb-2016
Trends in Parasitology
Virginia Tech researchers suggest gene drive strategy to combat harmful virus spread
Researchers discuss how recent breakthroughs in CRISPR-Cas9 gene editing technology coupled with theirdiscovery last year of a male sex determining gene Nix could be a winning combination for tipping the male-female mosquito ratio in the wild.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Lindsay Key
Virginia Tech

Public Release: 17-Feb-2016
Science Translational Medicine
New study finds promising results for MERS treatment
In a new study, University of Maryland School of Medicine researchers have had promising results with a new treatment for Middle East Respiratory Syndrome. The study, published today in the journal Science Translational Medicine, found a new treatment that protected mice from MERS infection.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 16-Feb-2016
Zika doesn't deter Americans from traveling abroad, study shows
Global concerns about Zika virus aren't stopping Americans from making international travel plans, a new study finds, but many who do plan to go abroad say they want more information about the virus.

Contact: Lori Pennington-Gray
University of Florida

Public Release: 16-Feb-2016
Family Medicine and Community Health
Care, disease management and sociobehavioral interventions in China and Australia
A Sino-Australian forum is the theme of the new issue of Family Medicine and Community Health. Australia and China share a number of similar health policy challenges. Both countries are working to reduce gaps in health services accessibility and in health outcomes between rich and poor, urban and rural and indigenous and nonindigenous people. This special issue of FMCH highlights the potential benefits from closer professional and institutional engagement.

Contact: Mogan Lyons
Family Medicine and Community Health

Public Release: 16-Feb-2016
New understanding of TB could lead to personalized treatments
TB killed 1.5 million people in 2014. This, combined with the increasing number of drug-resistant cases, means we need to look for new treatment options.

Contact: Helen Hanley
Trinity College Dublin

Public Release: 16-Feb-2016
BMC Infectious Diseases
Scientists discover genetic changes linked to a major risk factor for blinding trachoma
Another clue to the workings of trachoma -- the world's leading infectious cause of blindness -- has been revealed in a new study. Researchers identified markers of genetic regulation present in the early stages of infection that could predispose children to developing the condition in its long-term, severe form.
Fight for Sight and Wellcome Trust

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 15-Feb-2016
Scientific Reports
New study highlights effectiveness of a herpesvirus CMV-based vaccine against Ebola
As the latest in a series of studies, researchers have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model. Demonstration of protection in the NHP model is regarded as a critical step before translation of Ebola virus vaccines into humans and other great apes.

Contact: Andrew Gould
University of Plymouth

Showing releases 476-500 out of 1311.

<< < 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 > >>